Melanie A. Hundt, Yanhong Deng, Maria M. Ciarleglio, Michael H. Nathanson, Joseph K. Lim – 29 July 2020

Andrea D. Branch – 28 July 2020 – Coronavirus disease 2019 (COVID‐19) has created an emergency of epic proportions. While a vaccine may be forthcoming, this is not guaranteed, as discussed herein.

Nikolaos Perakakis, Aditya Joshi, Natia Peradze, Konstantinos Stefanakis, Georgia Li, Michael Feigh, Sanne Skovgard Veidal, Glenn Rosen, Michael Fleming, Christos S. Mantzoros – 28 July 2020 – CHS‐131 is a selective peroxisome proliferator‐activated receptor gamma modulator with antidiabetic effects and less fluid retention and weight gain compared to thiazolidinediones in phase II clinical trials. We investigated the effects of CHS‐131 on metabolic parameters and liver histopathology in a diet‐induced obese (DIO) and biopsy‐confirmed mouse model of nonalcoholic steatohepatitis (NASH).

Andrea D. Branch – 28 July 2020 – Coronavirus disease 2019 (COVID‐19) has created an emergency of epic proportions. While a vaccine may be forthcoming, this is not guaranteed, as discussed herein.

Adrian Reuben – 27 July 2020

Yong Chun Chong, Tan Boon Toh, Zhiling Chan, Quy Xiao Xuan Lin, Dexter Kai Hao Thng, Lissa Hooi, Zhaobing Ding, Timothy Shuen, Han Chong Toh, Yock Young Dan, Glenn Kunnath Bonney, Lei Zhou, Pierce Chow, Yulan Wang, Touati Benoukraf, Edward Kai‐Hua Chow, Weiping Han – 27 July 2020 – Tumor‐specific metabolic rewiring, acquired to confer a proliferative and survival advantage over nontransformed cells, represents a renewed focus in cancer therapy development.

Dmitrij Ostroumov, Steven Duong, Jessica Wingerath, Norman Woller, Michael P. Manns, Kai Timrott, Moritz Kleine, Wolf Ramackers, Stephanie Roessler, Sven Nahnsen, Stefan Czemmel, Oliver Dittrich‐Breiholz, Tobias Eggert, Florian Kühnel, Thomas C. Wirth – 27 July 2020

Gen‐Sheng Feng, Kaisa L. Hanley, Yan Liang, Xiaoxue Lin – 26 July 2020 – Hepatocellular carcinoma (HCC) is a most deadly malignant disease worldwide, with no effective mechanism‐based therapy available. Therefore, following the “miracle” outcomes seen in a few patients at the advanced stages of melanoma or lung cancer, the immune checkpoint inhibitors (ICIs) immediately entered clinical trials for advanced HCC patients without pre‐clinical studies.

Kajali Mishra, Sandra Naffouj, Sarah Gorgis, Hanan Ibrahim, Sonika Gill, Raef Fadel, Abigail Chatfield, Amy Tang, Reena Salgia – 26 July 2020 – Respiratory failure is the most common cause of death in patients with corona virus disease 2019 (COVID‐19). There have been many investigations to determine predictors of bad outcomes in patients with this illness. Liver enzyme elevation has been described in hospitalized patients with severe COVID‐19; however, little is known about the significance of liver injury regarding outcomes.

Kajali Mishra, Sandra Naffouj, Sarah Gorgis, Hanan Ibrahim, Sonika Gill, Raef Fadel, Abigail Chatfield, Amy Tang, Reena Salgia – 26 July 2020 – Respiratory failure is the most common cause of death in patients with corona virus disease 2019 (COVID‐19). There have been many investigations to determine predictors of bad outcomes in patients with this illness. Liver enzyme elevation has been described in hospitalized patients with severe COVID‐19; however, little is known about the significance of liver injury regarding outcomes.